Doctor of Philosophy in Human Biology and Pharmacology in Egaña, Chile at the presentation of the first clinical trial in the hospital del Salvador, after eight years of analysis and testing with animals (rats, pigs and fish), Santiago. Twenty patients with trauma.
"This step, which will last for six months, is small, but very important to demonstrate the safety of technology. If we can make it safe, we can apply it to other patients and patients, such as organ transplants and cancer patients," Egaña said to Efe.
This research, conducted at the Catholic University of Chile, developed a first technique to produce oxygen through the implantation of genetically modified microalgae and to make skin transplants to regenerate the area.
"90% of the cells in our bodies are not human. The human body is a real ecosystem of microorganisms and human cells. What we want to say is what happens in the body if we implant microalgae that produce photosynthesis?"
Photosynthesis is the process carried out by the Chilean scientist when they break water molecules of plants, releasing the oxygen of the light and the oxygen consumed by all living things on the planet.
Egaña, "The biggest question here, what if we could reproduce this process in a therapeutic context, because there are many diseases caused by lack of oxygen, such as bleeding, heart attack or big wounds that do not heal."
The first line of the study focuses on the possible applications of this technique for oxygenation through creams, bandages or sutures containing microorganisms that cause photosynthesis in wounds.
The second line investigates oncological therapies for further elimination of cancer cells while investigating the application of this technology in organ transplants to ensure that the organs live longer outside the body.
At the beginning of the study, Egaña developed a test in Lübeck University in Germany where he successfully awarded his doctorate, where a fish embryo injected with a small amount of microalgae and successfully combined it without 39 algae Araştır. They're gonna kill the embryo and kill the moss. "
As the researcher stresses today, the key to this initial clinical trial is to prevent patients from being rejected against these transplants.
If the skin is successfully regenerated by 20 patients, it is the removal or removal of the implant by the same body if the skin is regenerated.
In this sense, the next six months will be required for this technique to be applied in medicine in the future. EFE